Stock Report

Download full stock data and analysis for free Last Updated: 04-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Briacell Therapeutics Corp (BCTX) Key Ratios

Stock Card factsheet share-fund-plan-icon

$3.52

up-down-arrow $-0.05 (-1.36%)

As on 03-Sep-2026 13:35EDT

Market cap

info icon

$32 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

1.3

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 893.96 -- --
EBIT 6.01 15.70 -11.47 2.39 -284.02
Net Profit 2.55 15.24 -34.96 5.30 -285.68
EPS -- -- -- -- --
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMJul-25Jul-24
EBIT-Margin info -----16,965.60----
Net Margin info -----16,448.03----
Return on equity info -296.47-228.96-216.45-343.03114.78
Return on Capital info -296.47-228.74---343.03114.78
Return on Assets info -91.24-75.03-115.60-192.49-21.58
Debt to Equity (x) info ----0.00----

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
--
-343.03
114.78
-661.16
-143.83
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-216.45

Lower than Peers by 165.51

Profit after tax / Average Net worth * 100

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
-216.45
-343.03
114.78
-661.16
-143.93
Peer Median
-50.94
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-115.60

Lower than Peers by 68.77

Profit after tax / Average Total assets * 100

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
-115.60
-192.49
-21.58
-59.67
-54.14
Peer Median
-46.84
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-16,965.60

--

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
-16,965.60
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-16,448.03

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
-16,448.03
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

-0.19

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
-0.19
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

893.96

--

Year on year growth in net sales

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
893.96
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-11.47

Higher than Peers by 24.68

Year on year growth in operating profit (EBIT)

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
-11.47
-664.83
84.13
9.70
-100.47
Peer Median
-36.16
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-34.96

Higher than Peers by 14.00

Year on year growth in profit after tax

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
-34.96
-661.35
82.32
21.23
-99.34
Peer Median
-48.96
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

7.07

Higher than Peers by 1.23

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
7.07
5.01
0.49
14.96
45.00
Peer Median
5.84
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

7.07

Higher than Peers by 1.23

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
7.07
--
0.62
12.60
45.02
Peer Median
5.84
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-1,262.05

Lower than Peers by 1,233.97

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
-1,262.05
-735.69
--
--
-27,667.98
Peer Median
-28.08
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

1,148.82

--

Debtors outstanding / Net Sales * 100

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
1,148.82
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.01

--

Sales / Average Total Assets

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
0.01
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
--
-3,382.57
9,513.41
66,409.29
5,936.63
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
--
17,868.11
25,335.68
24,636.86
10,395.34
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Book Value

1.34

Lower than Peers by 1.72

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
1.34
--
--
--
--
Peer Median
3.07
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-1.38

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
-1.38
0.65
0.25
0.91
1.53
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

32

Lower than Peers by 9

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Jul-25
Jul-24
Jul-23
Jul-22
Briacell Therapeutics Corp (BCTX)
32
--
--
--
--
Peer Median
41
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...